Home > Insider Trading > Filing (0001179110-14-017086)

Filing Details

Accession Number:: 0001179110-14-017086
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-25 17:08:19
Reporting Period:: 2014-11-21

Filing Date:: 2014-11-25
Accepted Time:: 2014-11-25 17:08:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274057	Hospira Inc	HSP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1288288	J Brian Smith	C/O Hospira, Inc. 275 North Field Drive Lake Forest IL 60045	Svp And Special Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-11-21	48,300	$32.47	100,935	No	4	M	Direct
Commonstock	Disposition	2014-11-21	48,300	$59.34	52,635	No	4	S	Direct
Common Stock	Acquisiton	2014-11-21	1,300	$41.90	53,935	No	4	M	Direct
Common Stock	Disposition	2014-11-21	1,300	$59.13	52,635	No	4	S	Direct
Common Stock	Acquisiton	2014-11-24	1,700	$32.47	54,335	No	4	M	Direct
Common Stock	Disposition	2014-11-24	1,700	$59.00	52,635	No	4	S	Direct
Common Stock	Acquisiton	2014-11-24	33,700	$41.90	86,335	No	4	M	Direct
Common Stock	Disposition	2014-11-24	33,700	$59.31	52,635	No	4	S	Direct
Common Stock	Acquisiton	2014-11-24	38,000	$43.18	90,635	No	4	M	Direct
Common Stock	Disposition	2014-11-24	38,000	$59.02	52,635	No	4	S	Direct
Common Stock	Acquisiton	2014-11-24	62,700	$22.15	115,335	No	4	M	Direct
Common Stock	Disposition	2014-11-24	62,700	$59.48	52,635	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Acquisiton	2014-11-21	48,300	$0.00	48,300	$32.47
Common Stock	Stock Option (Right to Buy)	Acquisiton	2014-11-21	1,300	$0.00	1,300	$41.90
Common Stock	Stock Options (Right to Buy)	Acquisiton	2014-11-24	1,700	$0.00	1,700	$32.47
Common Stock	Stock Options	Acquisiton	2014-11-24	33,700	$0.00	33,700	$41.90
Common Stock	Stock Options	Acquisiton	2014-11-24	38,000	$0.00	38,000	$43.18
Common Stock	Stock Options (right to buy)	Acquisiton	2014-11-24	62,700	$0.00	62,700	$22.15

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,700	2015-05-08	No	4	M	Direct
33,700	2016-05-16	No	4	M	Direct
0	2015-05-08	No	4	M	Direct
0	2016-05-16	No	4	M	Direct
0	2015-03-05	No	4	M	Direct
0	2016-03-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,707	Indirect	See note 4.

Footnotes

The stock options, granted on May 9, 2005, vested in three equal installments on May 9, 2006, 2007, and 2008. The exercise price of $32.470 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on May 8, 2015.
Exercise of derivative security exempted pursuant to Rule 16b-3.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.48, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
Balance in the qualified Hospira 401(k) Retirement Savings Plan, as of November 25, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.13 to $59.14, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
The stock options, granted on May 17, 2006, vested in three equal installments on May 17, 20067 2008, and 2009. The exercise price of $41.900 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on May 16, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.24 to $59.58, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.16, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.40 to $59.51, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
The stock options, granted on March 6, 2008, vested in three equal installments on March 6, 2009, 2010, and 2011. The exercise price of $43.180 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on March 5, 2015.
The stock options, granted on March 5, 2009, vested in three equal installments on March 5, 2010, 2011, and 2012. The exercise price of $22.150 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on March 4, 2016.